| Nome |
# |
|
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression, file 114fed17-b83b-46da-91ef-667cebee5d84
|
308
|
|
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting, file e4233f17-5bd2-2860-e053-6605fe0a460a
|
115
|
|
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience, file e4233f16-1a32-2860-e053-6605fe0a460a
|
100
|
|
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage, file e4233f16-15f4-2860-e053-6605fe0a460a
|
84
|
|
null, file e4233f17-03df-2860-e053-6605fe0a460a
|
84
|
|
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody., file e4233f16-3733-2860-e053-6605fe0a460a
|
29
|
|
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study, file af98305d-13fa-42b5-8bd6-2e3e7fe2bd8b
|
27
|
|
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin, file e4233f15-d34c-2860-e053-6605fe0a460a
|
23
|
|
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial., file e4233f16-15f7-2860-e053-6605fe0a460a
|
23
|
|
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors, file e4233f18-50d2-2860-e053-6605fe0a460a
|
23
|
|
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer, file e4233f17-5d24-2860-e053-6605fe0a460a
|
22
|
|
Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma, file e4233f17-d007-2860-e053-6605fe0a460a
|
22
|
|
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer, file 750a3119-9409-45aa-b0c4-77c77b7408be
|
21
|
|
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice, file e4233f17-8f85-2860-e053-6605fe0a460a
|
21
|
|
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?, file e4233f16-1820-2860-e053-6605fe0a460a
|
20
|
|
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials, file e4233f17-03db-2860-e053-6605fe0a460a
|
19
|
|
Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage? Reply to Kadri Altundag, file e4233f16-1dd0-2860-e053-6605fe0a460a
|
18
|
|
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer, file 153c376a-53d2-4c7a-bba3-266492c3026d
|
17
|
|
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study, file e4233f17-747f-2860-e053-6605fe0a460a
|
17
|
|
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation", file e4233f17-9200-2860-e053-6605fe0a460a
|
17
|
|
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study, file e4233f17-962b-2860-e053-6605fe0a460a
|
16
|
|
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates, file e4233f18-97d7-2860-e053-6605fe0a460a
|
16
|
|
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial, file e4233f19-6a66-2860-e053-6605fe0a460a
|
16
|
|
Exosomes as pleiotropic players in pancreatic cancer, file e4233f18-87d9-2860-e053-6605fe0a460a
|
15
|
|
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression, file e4233f18-940d-2860-e053-6605fe0a460a
|
13
|
|
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey, file e4233f15-caa2-2860-e053-6605fe0a460a
|
12
|
|
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial, file e4233f16-27ed-2860-e053-6605fe0a460a
|
12
|
|
Eribulin in triple negative metastatic breast cancer: Critic interpretation of current evidence and projection for future scenarios, file e4233f17-a1a0-2860-e053-6605fe0a460a
|
12
|
|
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective, file e4233f17-ba93-2860-e053-6605fe0a460a
|
12
|
|
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: Current evidence and literature-based meta-analysis of randomized trials, file e4233f18-3daf-2860-e053-6605fe0a460a
|
12
|
|
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score, file e4233f18-d188-2860-e053-6605fe0a460a
|
11
|
|
Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2, file fe427b8f-59ec-4977-8d29-37867134d83e
|
11
|
|
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies, file e4233f15-0650-2860-e053-6605fe0a460a
|
10
|
|
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer, file e671c42f-90e1-4bbe-9e73-05250e4c5bcb
|
10
|
|
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting, file eefa9c0c-0a62-48a3-b14b-64ceadad9992
|
10
|
|
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study, file cbf6c109-9e4b-4d70-a8a0-4fbf9b6c2a48
|
9
|
|
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting, file c5838e51-8b69-42be-b4e0-7c0567e424dd
|
8
|
|
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer, file e4233f15-0a20-2860-e053-6605fe0a460a
|
8
|
|
Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: A systematic review, file e4233f15-babe-2860-e053-6605fe0a460a
|
8
|
|
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer, file e4233f16-1724-2860-e053-6605fe0a460a
|
8
|
|
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial, file 0886a523-3310-467a-b37c-fcddef01c985
|
7
|
|
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting, file 26826aa7-b457-45c4-ad25-a9a93cb38bfd
|
7
|
|
Alectinib induced regression of renal and hepatic cysts caused by crizotinib, file 5e173c4c-077d-4a35-a612-8319748f2396
|
7
|
|
The Role of the Environment and Type of Exercise on Acute Adrenal Modulation and Perceived Distress of Breast Cancer Survivors Practising Light-Intensity Physical Exercise, file e4233f19-6c70-2860-e053-6605fe0a460a
|
7
|
|
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study, file e1ff7b2d-1860-468c-8836-4204ca7fdc7f
|
6
|
|
Relationships between daily physical activity combinations and psychophysical health status of Italian breast cancer survivors, file e4233f18-f9da-2860-e053-6605fe0a460a
|
6
|
|
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer, file e4233f14-f164-2860-e053-6605fe0a460a
|
5
|
|
Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey, file e4233f15-3d95-2860-e053-6605fe0a460a
|
5
|
|
Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter "Tissue-Specific" Region, file e4233f19-0e2e-2860-e053-6605fe0a460a
|
5
|
|
Prognostic value of gender and primary tumor location in metastatic colon cancer, file df8f4303-0b81-4032-a91d-8f4e51621185
|
4
|
|
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial, file e4233f16-cc38-2860-e053-6605fe0a460a
|
4
|
|
Effects of activity tracker-based counselling and live-web exercise on breast cancer survivors’ sleep and waking time during Italy’s COVID-19 lockdown, file e4233f18-d51f-2860-e053-6605fe0a460a
|
4
|
|
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study, file e464dd36-283c-49e2-9d42-c0ea217e6824
|
4
|
|
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients, file 4e505980-bd6e-40c3-ae5f-f7710eddfe0a
|
3
|
|
An Epigenetic Approach to Pancreatic Cancer Treatment: the Prospective Role of Histone Deacetylase Inhibitors, file e4233f15-00ab-2860-e053-6605fe0a460a
|
3
|
|
New Targets for Therapy in Pancreatic Cancer, file e4233f15-00ac-2860-e053-6605fe0a460a
|
3
|
|
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience, file e4233f17-03d7-2860-e053-6605fe0a460a
|
3
|
|
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients, file 44acc7df-bf30-4688-a539-0ac30eb0b6b0
|
2
|
|
Flexibility and Strength Effects of Adapted Nordic Walking and Myofascial Exercises Practice in Breast Cancer Survivors and Analysis of Differences, file 48c1125b-87dc-4c83-bd84-09875a647b4d
|
2
|
|
null, file 7aac849c-2fda-48fd-a316-da3cd16bf4c0
|
2
|
|
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy, file 9ad61e64-d902-4872-8bb9-b41c01c9fb6b
|
2
|
|
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides., file e4233f14-edfc-2860-e053-6605fe0a460a
|
2
|
|
90K (Mac-2 BP) and galectins in tumor progression and metastasis., file e4233f14-ee19-2860-e053-6605fe0a460a
|
2
|
|
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer, file e4233f15-6e57-2860-e053-6605fe0a460a
|
2
|
|
Current challenges in HER2-positive breast cancer, file e4233f15-bf44-2860-e053-6605fe0a460a
|
2
|
|
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab, file e4233f16-98d4-2860-e053-6605fe0a460a
|
2
|
|
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation, file e4233f17-6ad0-2860-e053-6605fe0a460a
|
2
|
|
Occupational allergy: is there a role for nanoparticles?, file e4233f18-a34c-2860-e053-6605fe0a460a
|
2
|
|
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence, file aa4e8d13-0b2d-4534-b9ec-e537bcea210e
|
1
|
|
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer, file e4233f14-f0fb-2860-e053-6605fe0a460a
|
1
|
|
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein., file e4233f14-f190-2860-e053-6605fe0a460a
|
1
|
|
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice., file e4233f15-0176-2860-e053-6605fe0a460a
|
1
|
|
Tumor-derived microvesicles: The metastasomes., file e4233f15-079e-2860-e053-6605fe0a460a
|
1
|
|
Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer, file e4233f15-1291-2860-e053-6605fe0a460a
|
1
|
|
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study, file e4233f17-6224-2860-e053-6605fe0a460a
|
1
|
| Totale |
1.351 |